Skip to main content

Table 5 Postoperative outcomes

From: Prosthesis-patient mismatch after mitral valve replacement: a single-centered retrospective analysis in East China

  total PPM group non-PPM group P
Perioperative transfusion 269(25.2%) 47(24.9%) 222(25.3%) NS
Ventilation time (hr) 21(20–23) 21(20–23) 21(20–23) NS
Reintubation 3(0.3%) 0(0.0%) 3(0.3%) NS
Duration of first time ICU 72(72–96) 72(72–96) 72(72–96) NS
Reentering ICU 2(0.2%) 2(1.1%) 0(0.0%) NS
Chest tube output (ml) 545.88 ± 365.82 555.15 ± 295.51 543.87 ± 379.47 NS
Reoperation for bleeding 18(1.7%) 1(0.5%) 17(1.9%) NS
Sternal wound infection 3(0.3%) 0(0.0%) 3(0.3%) NS
Cerebral infarction 5(0.5%) 0(0.0%) 5(0.6%) NS
Postoperative stroke 1(0.1%) 0(0.0%) 1(0.1%) NS
Newly onset AF 3(0.3%) 0(0.0%) 3(0.3%) NS
Mortality within 30 days 9(0.8%) 2(1.1%) 7(0.8%) NS
Hospitalization expense (USD) 13,726
(11632–16,030)
14,446
(12538–17,010)
13,628
(11509–15,775)
0.032
Length of stay (d) 14(12–18) 15(13–19) 14(12–18) 0.011
  1. ICU intensive care unit, AF atrial fibrillation, NS not significant